雷蒙德-道格拉斯发布TED新药物最新临床报告
甲状腺眼病药物2019年最新进展
[Thyroid Thursday系列]关于药物治疗甲状腺眼病
Today, I'm gonna talk about Teprotumumab. 今天,我要谈谈Teprotumumab It's a tough name, but it's a drug that is being currently trialed for thyroid eye disease and been found to be very effective in reducing the bulging, double vision, and improving the quality of life of patients afflicted with this disease. 这是一个很难的名字,但它是一种药物,目前正在用来试验甲状腺眼病,并被发现在减少眼肿、双重视力、及改善患者的生活质量方面非常有效。 Briefly, I just wanted to talk about how it works, so that people can think about it and potentially en
版权所有:杭州微医健康科技有限公司 浙B2-20200356 浙卫(03)网审[2014]015号 (浙)-经营性-2014-0022